← All candidates
172 insider filings on record.
Jared MoskowitzHouse Select Subcommittee to Investigate the Remaining Questions Surrounding January 6, 2021 · Foreign Affairs +1traded 6 May · filed 19 Jun · selfBought$1K–$15Kself6 May134d ago19 Jun90d agoJared MoskowitzHouse Select Subcommittee to Investigate the Remaining Questions Surrounding January 6, 2021 · Foreign Affairs +1traded 6 May · filed 19 Jun · childBought$1K–$15Kchild6 May134d ago19 Jun172 filings on record.
GILDGILEAD SCIENCES, INC.
NasdaqGS · Healthcare · $183.12B
$147.68
+0.94% today
172 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 59 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$183.12B
Float
1237.3M
100% public
Short % float
Pro
Price / profit
18.3
Price / future profit
14.9
Price / sales
6.0
Congress
▸ Disclosures lag trades by 30–45 days.
4 disclosures12 mo
MemberTradeAmountOwnerTradedFiled
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
167 more transactions on Pro →Context
Wall St
$157.57 avg target
+6.7% vs today · 28 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26$2.03 act+$0.12
Q4 '25$1.86 act+$0.05
Q3 '25$2.47 act+$0.33
Q2 '25$2.01 act+$0.05
Coverage
FDA Accepts Gilead's Filing for Weekly Oral Yeztugo for HIV PreventionZacks · 06-16Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks · 06-15Regulatory Milestone Boosts Gilead’s Presence in Liver Disease CareInsider Monkey · 06-15Gilead’s New Liver Approvals Reframe PBC Goals And Revenue MixSimply Wall St. · 06-15
The file stays open
172 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice
